By Nicholas Megaw - Fianacial Times - Biotech companies are rushing to raise money in US equity markets at the fastest rate since the peak of the mid-pandemic market boom. Drug developers raised $6.2bn in equity capital markets in January, according to data from...

By Weill Cornell Medicine - A new study identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small cell lung cancer (NSCLC) treated with a combination of immunotherapy and low-dose radiation. The results, published in...

by Megan Giboney - RegMedNet - The US FDA has granted accelerated approval for AMTAGVI™ (lifileucel), a novel cell therapy for advanced melanoma. This is the first cell therapy to be approved by the FDA for the treatment of a solid tumor. AMTAGVI utilizes a population...

By University of California Irvine - Popular Science recently chose Quinton Smith, UC Irvine assistant professor of chemical and biomolecular engineering, as one of its Brilliant 10 scientists “on the cusp of changing the world” for his research on growing tissue from...

By the HSAC TEAM Healthspan Action Coalition (HSAC) is sponsoring The Livelong Summit™ to bring you an exclusive 2-day event featuring some of the greatest minds in medicine and longevity science. Because so many medical professionals have already signed up, we’ve...

By April Wendling, University of Illinois at Urbana-Champaign - Phys.org - CRISPR/Cas systems have undergone tremendous advancement in the past decade. These precise genome editing tools have applications ranging from transgenic crop development to gene therapy and...

By U. Rochester-URMC -  Futuirity - The American Red Cross is experiencing the most critical blood shortage in 20 years. Blood shortages are all too common, but they’re occurring more frequently now than ever before. Contact the Red Cross to find local blood drives...

Ben Andrew Henry - The Scientist - While studying a rare genetic disease, researchers discovered a signaling pathway linked to the efficiency of reprogramming somatic cells into stem cells. Thanks to a chance discovery, researchers have found a more efficient way to...

By Joseph Keenan - Fierce Pharma - Robotics specialist Multiply Labs and Thermo Fisher Scientific inked a deal to expand their partnership to further automate the cell therapy production process. The two companies will integrate Multiply Lab's robotic technology and...

By Tu Wien News A new approach to producing artificial tissue has been developed at TU Wien: Cells are grown in microstructures created in a 3D printer. Is it possible to grow tissue in the laboratory, for example to replace injured cartilage? At TU Wien (Vienna), an...

By Andrea Park -Fierce Biotech - For the first time since it launched in 2020 and began accepting submissions in 2022, a program started by the FDA to provide support for unconventional drug development tools has accepted its first artificial intelligence-powered...

by Technology Networks - Biopharma News - Initial trial suggests invariant natural killer cell therapy improves survival. Promising trial results indicate that a new type of cell therapy could improve the prognosis of those who are critically ill with acute...